Acenocoumarol as a risk factor for calciphylaxis: a feature clinicians should be aware of

被引:0
|
作者
Wenstedt, E. F. E. [1 ]
Huysentruyt, C. J. [2 ]
Konings, C. J. A. M. [1 ]
机构
[1] Catharina Hosp, Dept Internal Med, Eindhoven, Netherlands
[2] Catharina Hosp, Dept Pathol, Eindhoven, Netherlands
来源
NETHERLANDS JOURNAL OF MEDICINE | 2017年 / 75卷 / 04期
关键词
Calciphylaxis; acenocoumarol; warfarin; calcaemic uraemic arteriolopathy; vitamin K antagonist; non-uraemic; HYPERBARIC-OXYGEN; WARFARIN; PATIENT; THERAPY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In contrast with uraemic calciphylaxis in end-stage renal disease, causes of and risk factors for non-uraemic calciphylaxis are relatively unknown to clinicians and have yet to become fully established. This report describes a case of non-uraemic calciphylaxis, in which the use of acenocoumarol might have been a risk factor. It is important to raise awareness about this association among clinicians, as vitamin K antagonists have to be stopped for an optimal treatment of this severe condition.
引用
收藏
页码:161 / 164
页数:4
相关论文
共 50 条
  • [1] Interferon withdrawal; Something clinicians should aware.
    Myaing, M
    Goldsmith, JR
    Mendenhall, C
    Harrer, J
    Patton, D
    Muirhead, L
    Reese, C
    Morelli, J
    HEPATOLOGY, 2004, 40 (04) : 509A - 509A
  • [2] Metoclopramide induced acute dystonia: Clinicians should be aware
    Windy, M.
    Benkirane, R.
    Rhalem, N.
    Soulaymani, R.
    DRUG SAFETY, 2007, 30 (10) : 980 - 980
  • [3] Introduction: Rare and unusual andrologic syndromes that clinicians should be aware of
    Sigman, Mark
    FERTILITY AND STERILITY, 2020, 113 (01) : 4 - 5
  • [4] Endometriosis - Clinicians and patients should be aware of association between endometriosis and malignancies
    Amso, NN
    BRITISH MEDICAL JOURNAL, 2002, 324 (7329): : 115 - 115
  • [5] Factor XI inhibitors: what should clinicians know
    Pandey, Arjun
    Verma, Raj
    Eikelboom, John
    Verma, Subodh
    CURRENT OPINION IN CARDIOLOGY, 2023, 38 (02) : 88 - 93
  • [6] Calciphylaxis: Natural history, risk factor analysis, and outcome
    Weenig, Roger H.
    Sewell, Lindsay D.
    Davis, Mark D. P.
    McCarthy, James T.
    Pittelkow, Mark R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (04) : 569 - 579
  • [7] Five Ibrutinib-Associated Side Effects That All Clinicians Should Be Aware of
    Levy, Ilana
    Polliack, Aaron
    Tadmor, Tamar
    ACTA HAEMATOLOGICA, 2019, 141 (04) : 254 - 255
  • [8] Why Should Assessment Clinicians Care about Factor Analysis?
    Kurtz, John E.
    JOURNAL OF PERSONALITY ASSESSMENT, 2022, 104 (06) : 855 - 856
  • [9] Calcic uremic arteriolopathy (calciphylaxis):: an independant vascular risk factor?
    Bura-Rivière, A
    REVUE DE MEDECINE INTERNE, 2006, 27 (03): : 181 - 183
  • [10] Warfarin sodium is a risk factor for calciphylaxis in dialysis patients.
    Maitra, S
    Cheng, MM
    Ilumin, M
    Chu, M
    Bargman, JM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 387A - 387A